FOXP3 and acute myeloid leukemia: Recent findings have revealed that extracellular vesicles (EVs) derived from AML cells and containing 4-1BBL play a pivotal role in augmenting the expression of FOXP3 and the effector phenotype in Tregs, thereby bolstering their activity.